17. August 2018
In continuous manufacturing of solid dosage forms, continued assurance of process performance and product quality is based on accurate and consistent flow of solid materials. Acknowledging the multidimensionality of material flow properties is often the first step to explore the material knowledge space.
17. August 2018
This webinar explores how the choice of excipients can improve API stability in a solid dosage drug formulation. Abstract Many factors in a drug formulation can have a negative effect on the stability of the API, which can result in a reduced shelf life, less effective medicinal effect on the patient, or in the worst cases, harm to a patient. API stability can be negatively affected by various factors, including excipients. This webinar explores how the choice of excipients can improve API...
03. April 2018
Overview Webinar Title: Streamlined Manufacture of Modified Release Matrix Tablets via Direct Compression Date: Tuesday, April 10, 2018 Time: 11:00 AM Eastern Daylight Time Duration: 1 hour
19. February 2018
Solubility is the biggest challenge in the drug formulation processes. Register for the webinar Feb. 22, 11 AM EST as Kevin O'Donnell and I introduce our AFFINISOL™ and ENTERACT™ polymers for solubility enhancement and enteric delivery. http://bit.ly/2svU5Kq More on Dow Pharma Solutions
18. January 2018
A new feature of the revamped 2018 agenda is the expansion of the programme to cover advanced drug delivery devices and the areas of bioanalysis & stabilisation. Leading experts will discuss slow delivery devices for antibodies, needle-free delivery systems as well as updates in auto-injectors. The bioanalysis & stabilisation session will look at such areas as bioanalytical development for large molecules, prediction and characterisation of aggregates and particle-size analysis.
12. December 2017
IPEC-Americas and IPEC Europe have jointly published a guide for excipient makers and users on co-processed excipients. This guide offers best practice and voluntary guidance on the development, manufacture and use of co-processed excipients and provides support to both manufacturers and users of co-processed excipients.
14. July 2017
QbD applied through scientific approaches to the development and finalisation of LBF commercial processes can shorten project timelines while reducing risks and gaining valuable product knowledge.
13. August 2015
Get the Latest on the ICH Q3D Guideline for Elemental Impurities! Information Registration
13. August 2015
Key Learning Objectives - Learn how to make sure your excipients are regulatory compliant - Learn how to stay up-to-date on new excipient regulations - Learn how to track excipient regulations Information & Registration
25. May 2015
Orally Disintegrating Tablets (ODTs) are getting increasingly interesting delivery systems in the Pharmaceutical and Nutraceutical fields. This webinar will provide you important information to overcome the main challenges during the development of your ODT product. We will guide you toward a rational way for the selection of the right formulation. We will focus on the oral disintegration time and on the effect of the excipients on the ODT’s stability. More information and registration